EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis

Riona Aburaki, Yu Fujiwara, Kohei Chida, Nobuyuki Horita, Misako Nagasaka

Cancer Treatment Reviews · 2024-12 · 131 · 102833

DOI: 10.1016/j.ctrv.2024.102833 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2024-12. Verfasst von Riona Aburaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yokohama City University School of Medicine, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Neoadjuvant Therapy, Lung Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungNeoadjuvant TherapyLung NeoplasmsHumansImmunotherapyAntineoplastic Combined Chemotherapy ProtocolsImmune Checkpoint InhibitorsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Immune checkpoint blockadeMeta-analysisNeoadjuvant therapyNon-small cell lung cancerSurgical oncology

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Yokohama City University School of Medicine, Japan.
  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo NY USA; Department of Clinical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Elect…
  • Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Chemotherapy Center, Yokohama City University Hospital, Japan.
  • Division of Hematology and Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA.

Zitieren

APA

Aburaki, R., Fujiwara, Y., Chida, K., Horita, N., & Nagasaka, M. (2024). Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis. Cancer Treatment Reviews, 131, 102833. https://doi.org/10.1016/j.ctrv.2024.102833

Vancouver

Aburaki R, Fujiwara Y, Chida K, Horita N, Nagasaka M. Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis. Cancer Treatment Reviews. 2024;131:102833. doi:10.1016/j.ctrv.2024.102833

BibTeX
@article{Aburaki2024,
  author = {Aburaki, Riona and Fujiwara, Yu and Chida, Kohei and Horita, Nobuyuki and Nagasaka, Misako},
  title = {Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  volume = {131},
  pages = {102833},
  doi = {10.1016/j.ctrv.2024.102833}
}
Kostenlos starten →